Barclays initiated coverage of EssilorLuxottica (ESLOY) with an Overweight rating and EUR 305 price target The firm views EssilorLuxottica as a “quality compounder” with growth opportunities on lens differentiation, wearables and medical technology. The company’s vertical integration and positions across wholesale and retail “offer a robust competitive moat,” the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ESLOY:
- EssilorLuxottica’s Earnings Call Highlights Robust Growth
- EssilorLuxottica Reports Strong Growth in H1 2025
- EssilorLuxottica reports 1H revenue EUR 14.02B vs. EUR 13.29B last year
- EssilorLuxottica says AI glasses Ray-Ban Meta up more than 200% in sales in 1H
- EssilorLuxottica confirms target of mid single digit annual revenue growth